Tafenoquine
Tafenoquine (SB-252263, Tafenoquine, WR 238605) is a long-acting, orally active anti-malarial agent to prevent malaria that is holoendemic for Plasmodium falciparum.Parasite Infection Phase 3 Clinical (In Vitro) :Tafenoquine exhibits no anti-malarial activity in CYP 2D knock-out mice when dosed at their ED100 values (3 mg/kg) established in WT mice. Tafenoquine anti-malarial activity is partially restored in humanized/CYP 2D6 knock-in mice when tested at two times its ED100 (6 mg/kg) .
Product Specifications
CAS Number
106635-80-7
Product Name Alternative
SB-252263 | Tafenoquine | WR 238605
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Smiles
CC1=CC (=NC2=C1C (=C (C=C2NC (C) CCCN) OC) OC3=CC=CC (=C3) C (F) (F) F) OC
Molecular Formula
C24H28F3N3O3
Molecular Weight
463.501
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
N4- (2,6-dimethoxy-4-methyl-5- (3- (trifluoromethyl) phenoxy) quinolin-8-yl) pentane-1,4-diamine
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bovine Ankyrin repeat and SOCS box protein 18 (ASB18) ELISA Kit
Bovine Ankyrin repeat and SOCS box protein 18 (ASB18) ELISA Kit
Bovine Ankyrin repeat and SOCS box protein 18 (ASB18) ELISA Kit
Bovine Ankyrin repeat and SOCS box protein 18 (ASB18) ELISA Kit
MAPK3 (Mitogen-activated Protein Kinase 3, MAPK 3, MAP Kinase 3, ERT2, Extracellular Signal-regulated Kinase 1, ERK1, ERK-1, Insulin-stimulated MAP2 Kinase, MAP Kinase Isoform p44, Microtubule-associated Protein 2 Kinase, Mitogen-activated Protein Kinase 1, MAP Kinase 1, MAPK 1, P44ERK1, p44-ERK1, P44MAPK, p44-MAPK, PRKM3, MGC20180) (AP) discontinued
